Avanos Medical, Inc. financial data

Symbol
AVNS on NYSE
Location
5405 Windward Parkway, Suite 100 South, Alpharetta, GA
State of incorporation
DE
Fiscal year end
December 31
Former names
Halyard Health, Inc. (to 6/28/2018)
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 228 % -16.2%
Quick Ratio 79.6 % -13.8%
Debt-to-equity 36 % -1.72%
Return On Equity -34.8 % -603%
Return On Assets -25.6 % -606%
Operating Margin -57.6 % -9335%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46M shares +0.22%
Common Stock, Shares, Outstanding 46M shares -0.46%
Entity Public Float 907M USD -23.9%
Common Stock, Value, Issued 500K USD 0%
Weighted Average Number of Shares Outstanding, Basic 46M shares -1.29%
Weighted Average Number of Shares Outstanding, Diluted 46M shares -1.29%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 688M USD +2.15%
Research and Development Expense 26.2M USD -3.68%
Operating Income (Loss) -396M USD -9533%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -403M USD -5005%
Income Tax Expense (Benefit) -17M USD -950%
Net Income (Loss) Attributable to Parent -392M USD -534%
Earnings Per Share, Basic -8.53 USD/shares -546%
Earnings Per Share, Diluted -8.53 USD/shares -546%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 108M USD +22.8%
Inventory, Net 139M USD -15%
Assets, Current 393M USD -19.2%
Deferred Income Tax Assets, Net 24.9M USD +283%
Property, Plant and Equipment, Net 111M USD -5.55%
Operating Lease, Right-of-Use Asset 34.1M USD +27.2%
Intangible Assets, Net (Excluding Goodwill) 112M USD -53.1%
Goodwill 456M USD -42.8%
Other Assets, Noncurrent 23.2M USD +20.2%
Assets 1.15B USD -31.8%
Accounts Payable, Current 54.3M USD -3.55%
Accrued Liabilities, Current 91.3M USD -2.04%
Liabilities, Current 166M USD -29.3%
Deferred Income Tax Liabilities, Net 5.5M USD -76.9%
Operating Lease, Liability, Noncurrent 24.6M USD -13.1%
Other Liabilities, Noncurrent 4.4M USD -56%
Liabilities 326M USD -28.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -44.6M USD -65.2%
Retained Earnings (Accumulated Deficit) -707M USD -125%
Stockholders' Equity Attributable to Parent 829M USD -33%
Liabilities and Equity 1.15B USD -31.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8M USD -17.6%
Net Cash Provided by (Used in) Financing Activities -700K USD +96.8%
Net Cash Provided by (Used in) Investing Activities -2M USD +50%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.9M USD +62.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 108M USD +22.8%
Deferred Tax Assets, Valuation Allowance 3.9M USD -9.3%
Deferred Tax Assets, Gross 59.2M USD +2.6%
Operating Lease, Liability 35.5M USD -13.6%
Depreciation 20.3M USD +5.73%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -410M USD -673%
Lessee, Operating Lease, Liability, to be Paid 48.2M USD -9.4%
Property, Plant and Equipment, Gross 249M USD +3.87%
Operating Lease, Liability, Current 10.9M USD -14.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.4M USD -20.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.2M USD -17%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +22.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.9M USD -49.4%
Deferred Tax Assets, Operating Loss Carryforwards 8.4M USD -18.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.5M USD -43.5%
Additional Paid in Capital 1.68B USD +0.9%
Amortization of Intangible Assets 25.2M USD +3.7%
Depreciation, Depletion and Amortization 11.4M USD -5.79%
Deferred Tax Assets, Net of Valuation Allowance 55.3M USD +3.56%
Share-based Payment Arrangement, Expense 13.8M USD -12.7%
Interest Expense 14.6M USD +19.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%